Lin D, Wang M, Chen Y, Gong J, Chen L, Shi X, Lan F, Chen Z, Xiong T, Sun H, Wan S. Trends in intracranial glioma incidence and mortality in the United States, 1975–2018. Front Oncol. 2021;11:748061. https://doi.org/10.3389/fonc.2021.748061.

Article  PubMed  PubMed Central  Google Scholar 

Back MF, Ang EL, Ng WH, See SJ, Lim CC, Chan SP, Yeo TT. Improved median survival for glioblastoma multiforme following introduction of adjuvant temozolomide chemotherapy. Ann Acad Med Singap. 2007;36(5):338–42.

Article  PubMed  Google Scholar 

Virga J, Szivos L, Hortobágyi T, Chalsaraei MK, Zahuczky G, Steiner L, Tóth J, Reményi-Puskár J, Bognár L, Klekner A. Extracellular matrix differences in glioblastoma patients with different prognoses. Oncol Lett. 2017;17(1):797–806. https://doi.org/10.3892/ol.2018.9649.

Article  CAS  Google Scholar 

Rong L, Li N, Zhang Z. Emerging therapies for glioblastoma: current state and future directions. J Exp Clin Cancer Res. 2022;41(1):142. https://doi.org/10.1186/s13046-022-02349-7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arora A, Somasundaram K. Glioblastoma vs temozolomide: can the red queen race be won? Cancer Biol Ther. 2019;20(8):1083–90. https://doi.org/10.1080/15384047.2019.1599662.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO, European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups; National Cancer Institute of Canada Clinical Trials Group. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10(5):459–66. https://doi.org/10.1016/S1470-2045(09)70025-7.

Article  CAS  PubMed  Google Scholar 

Lathia JD, Mack SC, Mulkearns-Hubert EE, Valentim CL, Rich JN. Cancer stem cells in glioblastoma. Genes Dev. 2015;29(12):1203–17. https://doi.org/10.1101/gad.261982.115.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alfonso J, Talkenberger K, Seifert M, Klink B, Hawkins-Daarud A, Swanson KR, Hatzikirou H, Deutsch A. The biology and mathematical modelling of glioma invasion: a review. J R Soc Interface. 2017;14(136):20170490. https://doi.org/10.1098/rsif.2017.0490.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Inoue A, Takahashi H, Harada H, Kohno S, Ohue S, Kobayashi K, Yano H, Tanaka J, Ohnishi T. Cancer stem-like cells of glioblastoma characteristically express MMP-13 and display highly invasive activity. Int J Oncol. 2010;37(5):1121–31. https://doi.org/10.3892/ijo_00000764.

Article  CAS  PubMed  Google Scholar 

Gonzalez-Avila G, Sommer B, Mendoza-Posada DA, Ramos C, Garcia-Hernandez AA, Falfan-Valencia R. Matrix metalloproteinases participation in the metastatic process and their diagnostic and therapeutic applications in cancer. Crit Rev Oncol Hematol. 2019;137:57–83. https://doi.org/10.1016/j.critrevonc.2019.02.010.

Article  PubMed  Google Scholar 

Hagemann C, Anacker J, Ernestus RI, Vince GH. A complete compilation of matrix metalloproteinase expression in human malignant gliomas. World J Clin Oncol. 2012;3(5):67–79. https://doi.org/10.5306/wjco.v3.i5.67.

Article  PubMed  PubMed Central  Google Scholar 

Abdel-Hamid NM, Abass SA. Matrix metalloproteinase contribution in management of cancer proliferation, metastasis and drug targeting. Mol Biol Rep. 2021;48(9):6525–38. https://doi.org/10.1007/s11033-021-06635-z.

Article  CAS  PubMed  Google Scholar 

Liang W, Chen Y, Li X, Guo F, Sun J, Zhang X, Xu B, Gao W. Label-free proteomic analysis of smoke-drying and shade-drying processes of postharvest rhubarb: a comparative study. Front Plant Sci. 2021;12:663180. https://doi.org/10.3389/fpls.2021.663180.

Article  PubMed  PubMed Central  Google Scholar 

Niinaka Y, Paku S, Haga A, Watanabe H, Raz A. Expression and secretion of neuroleukin/phosphohexose isomerase/maturation factor as autocrine motility factor by tumor cells. Cancer Res. 1998;58(12):2667–74.

CAS  PubMed  Google Scholar 

Watanabe H, Carmi P, Hogan V, Raz T, Silletti S, Nabi IR, Raz A. Purification of human tumor cell autocrine motility factor and molecular cloning of its receptor. J Biol Chem. 1991;266(20):13442–8.

Article  CAS  PubMed  Google Scholar 

Kathagen-Buhmann A, Maire CL, Weller J, Schulte A, Matschke J, Holz M, Ligon KL, Glatzel M, Westphal M, Lamszus K. The secreted glycolytic enzyme GPI/AMF stimulates glioblastoma cell migration and invasion in an autocrine fashion but can have anti-proliferative effects. Neuro Oncol. 2018;20(12):1594–605. https://doi.org/10.1093/neuonc/noy117.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gallardo-Pérez JC, Adán-Ladrón de Guevara A, Marín-Hernández A, Moreno-Sánchez R, Rodríguez-Enríquez S. HPI/AMF inhibition halts the development of the aggressive phenotype of breast cancer stem cells. Biochim Biophys Acta Mol Cell Res. 2017;1864(10):1679–90. https://doi.org/10.1016/j.bbamcr.2017.06.015.

Article  CAS  PubMed  Google Scholar 

Manuel Iglesias J, Beloqui I, Garcia-Garcia F, Leis O, Vazquez-Martin A, Eguiara A, Cufi S, Pavon A, Menendez JA, Dopazo J, Martin AG. Mammosphere formation in breast carcinoma cell lines depends upon expression of E-cadherin. PLoS ONE. 2013;8(10):e77281. https://doi.org/10.1371/journal.pone.0077281.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gallardo-Pérez JC, Rivero-Segura NA, Marín-Hernández A, Moreno-Sánchez R, Rodríguez-Enríquez S. GPI/AMF inhibition blocks the development of the metastatic phenotype of mature multi-cellular tumor spheroids. Biochim Biophys Acta. 2014;1843(6):1043–53. https://doi.org/10.1016/j.bbamcr.2014.01.013.

Article  CAS  PubMed  Google Scholar 

Jiménez-García LF, Segura-Valdez ML. Visualizing nuclear structure in situ by atomic force microscopy. Methods Mol Biol. 2004;242:191–9. https://doi.org/10.1385/1-59259-647-9:191.

Article  PubMed  Google Scholar 

Zhao J, Zhang J, Yu M, Xie Y, Huang Y, Wolff DW, Abel PW, Tu Y. Mitochondrial dynamics regulates migration and invasion of breast cancer cells. Oncogene. 2013;32(40):4814–24. https://doi.org/10.1038/onc.2012.494.

Article  CAS  PubMed  Google Scholar 

Liu LL, Yi T, Zhao X. Antitumor effect of d-erythrose in an abdominal metastatic model of colon carcinoma. Oncol Lett. 2015;9(2):769–73. https://doi.org/10.3892/ol.2014.2764.

Article  PubMed  Google Scholar 

Pandey V, Ranjan N, Narne P, Babu PP. Roscovitine effectively enhances antitumor activity of temozolomide in vitro and in vivo mediated by increased autophagy and Caspase-3 dependent apoptosis. Sci Rep. 2019;9(1):5012. https://doi.org/10.1038/s41598-019-41380-1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Oliver L, Lalier L, Salaud C, Heymann D, Cartron PF, Vallette FM. Drug resistance in glioblastoma: are persisters the key to therapy? Cancer Drug Resist. 2020;3(3):287–301. https://doi.org/10.20517/cdr.2020.29.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stylli SS. Novel treatment strategies for glioblastoma-a summary. Cancers (Basel). 2021;13(22):5868. https://doi.org/10.3390/cancers13225868.

Article  PubMed  Google Scholar 

Yusuf S, Aretz P, Nickel AC, Westhoff P, Sharma A, Qin N, Remke M, Steiger HJ, Hänggi D, Liu H, Liu H, Neumann S, Reifenberger G, Maciaczyk J. WNT/β-catenin-mediated resistance to glucose deprivation in glioblastoma stem-like cells. Cancers. 2022;14(13):3165. https://doi.org/10.3390/cancers14133165.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vyas S, Zaganjor E, Haigis MC. Mitochondria and cancer. Cell. 2016;166(3):555–66. https://doi.org/10.1016/j.cell.2016.07.002.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gallardo-Pérez JC, de Guevara AA, García-Amezcua MA, Robledo-Cadena DX, Pacheco-Velázquez SC, Belmont-Díaz JA, Vargas-Navarro JL, Moreno-Sánchez R, Rodríguez-Enríquez S. Celecoxib and dimethylcelecoxib block oxidative phosphorylation, epithelial–mesenchymal transition and invasiveness in breast cancer stem cells. Curr Med Chem. 2022;29(15):2719–35. https://doi.org/10.2174/0929867328666211005124015.

Article  CAS  PubMed  Google Scholar 

Bordi M, Nazio F, Campello S. The close interconnection between mitochondrial dynamics and mitophagy in cancer. Front Oncol. 2017;7:81. https://doi.org/10.3389/fonc.2017.00081.

Article  PubMed  PubMed Central  Google Scholar 

Wang S, Shi X, Wei S, Ma D, Oyinlade O, Lv SQ, Ying M, Zhang YA, Claypool SM, Watkins P, Xia S. Krüppel-like factor 4 (KLF4) induces mitochondrial fusion and increases spare respiratory capacity of human glioblastoma cells. J Biol Chem. 2018;293(17):6544–55. https://doi.org/10.1074/jbc.RA117.001323.

Article  CAS  PubMed  PubMed Central  Google Scholar 

López de Andrés J, Griñán-Lisón C, Jiménez G, Marchal JA. Cancer stem cell secretome in the tumor microenvironment: a key point for an effective personalized cancer treatment. J Hematol Oncol. 2020;13(1):136. https://doi.org/10.1186/s13045-020-00966-3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li Y, Wei Z, Dong B, Lian Z, Xu Y. Silencing of phosphoglucose isomerase/autocrine motility factor decreases U87 human glioblastoma cell migration. Int J Mol Med. 2016;37(4):998–1004. https://doi.org/10.3892/ijmm.2016.2500.

Article  CAS  PubMed  PubMed Central